Budesonide for treating eosinophilic oesophagitis:: A single technology appraisal

Picot, Joanna, Cooper, Keith, Kalita, Neelam, Scott, David Alexander and Shepherd, Jonathan (2019) Budesonide for treating eosinophilic oesophagitis:: A single technology appraisal (Health Technology Assessment, HTA - NIHR127897) National Institute for Health and Care Research 99pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company's submission (CS) to NICE from Dr. Falk Pharma on the clinical effectiveness and cost effectiveness of orodispersible budesonide (brand name Jorveza) for eosinophilic oesophagitis (EoE). It identifies the strengths and weakness of the CS.

Text

Budesonide ERG report - Other

Restricted to Repository staff only

Request a copy

Text

Budesonide Addendum - Other

Restricted to Repository staff only

Request a copy

More information

Published date: 2019

Related URLs:

Identifiers

Local EPrints ID: 451104

URI: http://eprints.soton.ac.uk/id/eprint/451104

PURE UUID: 88d7e537-0a16-4a27-b9ce-c45445d45978

ORCID for Joanna Picot:

orcid.org/0000-0001-5987-996X

ORCID for Keith Cooper:

orcid.org/0000-0002-0318-7670

ORCID for Neelam Kalita:

orcid.org/0000-0002-0973-0160

ORCID for David Alexander Scott:

orcid.org/0000-0001-6475-8046

ORCID for Jonathan Shepherd:

orcid.org/0000-0003-1682-4330

Catalogue record

Date deposited: 07 Sep 2021 16:35

Last modified: 10 Apr 2024 02:03

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Joanna Picot

Author: Keith Cooper

Author: Neelam Kalita

Author: David Alexander Scott

Author: Jonathan Shepherd

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information